Table of Content

1. Research Framework
1.1. Research Objective
1.2. Product Type Overview
1.3. Market Segmentation

2. Research Methodology
2.1. Qualitative Research
2.1.1. Primary and Secondary Sources
2.2. Quantitative Research
2.2.1. Primary and Secondary Sources
2.3. Breakdown of Primary Research Respondents
2.3.1. Secondary Research
2.3.2. Primary Research
2.4. Breakdown of Primary Research Respondents, By Industry Participants
2.5. Key Questionnaire asked during Primary Interviews
2.6. Key Primary Responses
2.7. Market Size Estimation
2.8. Assumption for the Study
2.9. Market Breakdown & Data Triangulation

3. Executive Summary

4. Global Generic Drugs Market – Industry Insights
4.1. Industry Value Chain/Supply Chain
4.2. DROC Analysis
4.2.1. Growth Drivers
4.2.2. Restraints
4.2.3. Opportunity
4.2.4. Challenges
4.3. Recent Developments / Technical Landscape
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis

5. Global Generic Drugs Market Overview, 2018-2028
5.1. Market Size & Forecast
5.1.1. By Value (USD Billion)
5.2. Market Share & Forecast
5.2.1. By Product Type
5.2.1.1. Simple Generics
5.2.1.2. Super Generics
5.2.1.3. Biosimilars
5.2.2. By Route of Administration
5.2.2.1. Oral
5.2.2.2. Topical
5.2.2.3. Injectable
5.2.2.4. Others
5.2.3. By Application
5.2.3.1. Cardiovascular Products
5.2.3.2. Anti-infective Drugs
5.2.3.3. Anti-arthritis Drugs
5.2.3.4. Central Nervous System Drugs
5.2.3.5. Anti-Cancer Drugs
5.2.3.6. Respiratory Products
5.2.3.7. Other
5.2.4. By Distribution Channel
5.2.4.1. Hospitals/Clinics
5.2.4.2. Retail Pharmacies
5.2.4.3. Other
5.2.5. Region
5.2.5.1. North America
5.2.5.2. Europe
5.2.5.3. Asia-Pacific
5.2.5.4. Latin America
5.2.5.5. Middle East & Africa

6. North America Generic Drugs Market Overview, 2018-2028
6.1. Market Size & Forecast
6.1.1. By Value (USD Billion)
6.2. Market Share & Forecast
6.2.1. By Product Type
6.2.2. By Route of Administration
6.2.3. By Application
6.2.4. By Distribution Channel
6.2.5. By Country
6.2.5.1. United States
6.2.5.2. Canada

7. Europe Generic Drugs Market Overview, 2018-2028
7.1. Market Size & Forecast
7.1.1. By Value (USD Billion)
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Route of Administration
7.2.3. By Application
7.2.4. By Distribution Channel
7.2.5. By Country
7.2.5.1. Germany
7.2.5.2. France
7.2.5.3. Italy
7.2.5.4. Spain
7.2.5.5. UK
7.2.5.6. Netherlands
7.2.5.7. Rest of Europe

8. Asia-Pacific Generic Drugs Market Overview, 2018-2028
8.1. Market Size & Forecast
8.1.1. By Value (USD Billion)
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Route of Administration
8.2.3. By Application
8.2.4. By Distribution Channel
8.2.5. By Country
8.2.5.1. China
8.2.5.2. India
8.2.5.3. Japan
8.2.5.4. South Korea
8.2.5.5. Rest of Asia-Pacific

9. Latin America Generic Drugs Market Overview, 2018-2028
9.1. Market Size & Forecast
9.1.1. By Value (USD Billion)
9.2. Market Share & Forecast
9.2.1. By Product Type
9.2.2. By Route of Administration
9.2.3. By Application
9.2.4. By Distribution Channel
9.2.5. By Country
9.2.5.1. Argentina
9.2.5.2. Brazil
9.2.5.3. Mexico
9.2.5.4. Rest of Latin America

10. Middle East & Africa Generic Drugs Market Overview, 2018-2028
10.1. Market Size & Forecast
10.1.1. By Value (USD Billion)
10.2. Market Share & Forecast
10.2.1. By Product Type
10.2.2. By Route of Administration
10.2.3. By Application
10.2.4. By Distribution Channel
10.2.5. By Country
10.2.5.1. Saudi Arabia
10.2.5.2. South Africa
10.2.5.3. UAE
10.2.5.4. Rest of Middle East & Africa

11. Competitive Landscape
11.1.1. List of Key Producers and Their Offerings
11.1.2. Market Share / Ranking Analysis (2021)
11.1.3. Competitive Benchmarking, By Operating Parameters
11.1.4. Key Developments & Growth Strategies
11.1.4.1. Mergers & Acquisitions

12. COVID-19 Impact

13. Company Profiles (Company Overview, Financial Matrix, Key Product Type landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *
13.1. Teva Pharmaceutical Industries
13.2. Fresenius Kabi
13.3. Sandoz, a Novartis Divison
13.4. Mylan N.V.
13.5. Sanofi S.A.
13.6. Sun Pharmaceutical Industries Limited
13.7. Mallinckrodt Pharmaceuticals
13.8. Stada Arzneimittel AG
13.9. Aurobindo Pharma Limited
13.10. Endo International plc.
13.11. Aspen Pharmacare Holdings Limited
13.12. Dr. Reddy’s Laboratories
13.13. Cipla Limited
13.14. Hikma Pharmaceuticals plc.
13.15. Piramal Pharma Solutions
13.16. LUPIN Limited
13.17. Sawai Pharmaceutical Co. Ltd.
13.18. Amneal Pharmaceuticals, Inc.
13.19. Glenmark Pharmaceuticals Limited
13.20. Torrent Pharmaceuticals Ltd.
13.21. Other Prominent Players

14. Key Strategic Recommendations

* Financial information of non-listed Companies will be provided as per availability
**The segmentation and the companies are subjected to modifications based on in-depth study during the final deliverable.

List of Figures
Fig 1: Global Generic Drugs Segmentation
Fig 2: Global Generic Drugs Market Value Chain Analysis
Fig 3: Global Generic Drugs Market Size, By Value (USD Billion), 2018-2028
Fig 4: Global Generic Drugs Market Share, By Product Type, By Value, 2018-2028
Fig 5: Global Generic Drugs Market Share, By Route of Administration, By Value, 2018-2028
Fig 6: Global Generic Drugs Market Share, By Application, By Value, 2018-2028
Fig 7: Global Generic Drugs Market Share, By Distribution Channel, By Value, 2018-2028
Fig 8: Global Generic Drugs Market Share, By Region, By Value, 2018-2028
Fig 9: North America Generic Drugs Market Size, By Value (USD Billion), 2018-2028
Fig 10: North America Generic Drugs Market Share, By Product Type, By Value, 2018-2028
Fig 11: North America Generic Drugs Market Share, By Route of Administration, By Value, 2018-2028
Fig 12: North America Generic Drugs Market Share, By Application, By Value, 2018-2028
Fig 13: North America Generic Drugs Market Share, By Distribution Channel, By Value, 2018-2028
Fig 14: North America Generic Drugs Market Share, By Country By Value, 2018-2028
Fig 15: Europe Generic Drugs Market Size, By Value (USD Billion), 2018-2028
Fig 16: Europe Generic Drugs Market Share, By Product Type, By Value, 2018-2028
Fig 17: Europe Generic Drugs Market Share, By Route of Administration, By Value, 2018-2028
Fig 18: Europe Generic Drugs Market Share, By Application, By Value, 2018-2028
Fig 19: Europe Generic Drugs Market Share, By Distribution Channel, By Value, 2018-2028
Fig 20: Europe Generic Drugs Market Share, By Country By Value, 2018-2028
Fig 21: Asia-Pacific Generic Drugs Market Size, By Value (USD Billion), 2018-2028
Fig 22: Asia-Pacific Generic Drugs Market Share, By Product Type, By Value, 2018-2028
Fig 23: Asia-Pacific Generic Drugs Market Share, By Route of Administration, By Value, 2018-2028
Fig 24: Asia-Pacific Generic Drugs Market Share, By Application, By Value, 2018-2028
Fig 25: Asia-Pacific Generic Drugs Market Share, By Distribution Channel, By Value, 2018-2028
Fig 26: Asia-Pacific Generic Drugs Market Share, By Country By Value, 2018-2028
Fig 27: Latin America Generic Drugs Market Size, By Value (USD Billion), 2018-2028
Fig 28: Latin America Generic Drugs Market Share, By Product Type, By Value, 2018-2028
Fig 29: Latin America Generic Drugs Market Share, By Route of Administration, By Value, 2018-2028
Fig 30: Latin America Generic Drugs Market Share, By Application, By Value, 2018-2028
Fig 31: Latin America Generic Drugs Market Share, By Distribution Channel, By Value, 2018-2028
Fig 32: Latin America Generic Drugs Market Share, By Country By Value, 2018-2028
Fig 33: Middle East & Africa Generic Drugs Market Size, By Value (USD Billion), 2018-2028
Fig 34: Middle East & Africa Generic Drugs Market Share, By Product Type, By Value, 2018-2028
Fig 35: Middle East & Africa Generic Drugs Market Share, By Route of Administration, By Value, 2018-2028
Fig 36: Middle East & Africa Generic Drugs Market Share, By Application, By Value, 2018-2028
Fig 37: Middle East & Africa Generic Drugs Market Share, By Distribution Channel, By Value, 2018-2028
Fig 38: Middle East & Africa Generic Drugs Market Share, By Country By Value, 2018-2028
Fig 39: Company Share Analysis, 2021

List of Tables

Table 1: Global Generic Drugs Size, By Product Type, By Value, 2018-2028
Table 2: Global Generic Drugs Market Size, By Route of Administration, By Value, 2018-2028
Table 3: Global Generic Drugs Market Size, By Application, By Value, 2018-2028
Table 4: Global Generic Drugs Market Size, By Distribution Channel, By Value, 2018-2028
Table 5: Global Generic Drugs Market Size, By Region, By Value, 2018-2028
Table 6: North America Generic Drugs Size, By Product Type, By Value, 2018-2028
Table 7: North America Generic Drugs Market Size, By Route of Administration, By Value, 2018-2028
Table 8: North America Generic Drugs Market Size, By Application, By Value, 2018-2028
Table 9: North America Generic Drugs Market Size, By Distribution Channel, By Value, 2018-2028
Table 10: North America Generic Drugs Market Size, By Region, By Value, 2018-2028
Table 11: Europe Generic Drugs Size, By Product Type, By Value, 2018-2028
Table 12: Europe Generic Drugs Market Size, By Route of Administration, By Value, 2018-2028
Table 13: Europe Generic Drugs Market Size, By Application, By Value, 2018-2028
Table 14: Europe Generic Drugs Market Size, By Distribution Channel, By Value, 2018-2028
Table 15: Europe Generic Drugs Market Size, By Region, By Value, 2018-2028
Table 16: Asia-Pacific Generic Drugs Size, By Product Type, By Value, 2018-2028
Table 17: Asia-Pacific Generic Drugs Market Size, By Route of Administration, By Value, 2018-2028
Table 18: Asia-Pacific Generic Drugs Market Size, By Application, By Value, 2018-2028
Table 19: Asia-Pacific Generic Drugs Market Size, By Distribution Channel, By Value, 2018-2028
Table 20: Asia-Pacific Generic Drugs Market Size, By Region, By Value, 2018-2028
Table 21: Latin America Generic Drugs Size, By Product Type, By Value, 2018-2028
Table 22: Latin America Generic Drugs Market Size, By Route of Administration, By Value, 2018-2028
Table 23: Latin America Generic Drugs Market Size, By Application, By Value, 2018-2028
Table 24: Latin America Generic Drugs Market Size, By Distribution Channel, By Value, 2018-2028
Table 25: Latin America Generic Drugs Market Size, By Region, By Value, 2018-2028
Table 26: Middle East & Africa Generic Drugs Size, By Product Type, By Value, 2018-2028
Table 27: Middle East & Africa Generic Drugs Market Size, By Route of Administration, By Value, 2018-2028
Table 28: Middle East & Africa Generic Drugs Market Size, By Application, By Value, 2018-2028
Table 29: Middle East & Africa Generic Drugs Market Size, By Distribution Channel, By Value, 2018-2028
Table 30: Middle East & Africa Generic Drugs Market Size, By Region, By Value, 2018-2028
Table 31: Teva Pharmaceutical Industries Business Overview
Table 32: Teva Pharmaceutical Industries Financial Analysis
Table 33: Fresenius Kabi Business Overview
Table 34: Fresenius Kabi Financial Overview
Table 35: Sandoz, A Novartis division Business Overview
Table 36: Sandoz, A Novartis division Financial Overview
Table 37: Mylan N.V., Business Overview
Table 38: Mylan N.V., Financial Overview
Table 39: Sanofi S.A., Business Overview
Table 40: Sanofi S.A., Financial Overview
Table 41: Sun Pharmaceutical Industries Limited Business Overview
Table 42: Sun Pharmaceutical Industries Limited Financial Analysis
Table 43: Mallinckrodt Pharmaceuticals Business Overview
Table 44: Mallinckrodt Pharmaceuticals Financial Analysis
Table 45: Stada Arzneimittel AG Business Overview
Table 46: Stada Arzneimittel AG Financial Analysis
Table 47: Aurobindo Pharma Limited Business Overview
Table 48: Aurobindo Pharma Limited Financial Overview
Table 49: Endo International plc., Business Overview
Table 50: Endo International plc., Financial Overview
Table 51: Aspen Pharmacare Holdings Limited Business Overview
Table 52: Aspen Pharmacare Holdings Limited Financial Overview
Table 53: Dr. Reddy’s Laboratories Business Overview
Table 54: Dr. Reddy’s Laboratories Financial Analysis
Table 55: Cipla Limited Business Overview
Table 56: Cipla Limited Financial Overview
Table 57: Hikma Pharmaceuticals plc., Business Overview
Table 58: Hikma Pharmaceuticals plc., Financial Overview
Table 59: Primal Pharma Solutions Business Overview
Table 60: Primal Pharma Solutions Financial Overview
Table 61: Lupin Limited Business Overview
Table 62: Lupin Limited Financial Overview
Table 63: Sawai Pharmaceutical Co. Ltd., Business Overview
Table 64: Sawai Pharmaceutical Co. Ltd., Financial Overview
Table 65: Amneal Pharmaceuticals, Inc., Business Overview
Table 66: Amneal Pharmaceuticals, Inc. Financial Overview
Table 67: Glenmark Pharmaceuticals Limited Business Overview
Table 68: Glenmark Pharmaceuticals Limited Financial Overview
Table 69: Torrent Pharmaceuticals Ltd., Business Overview
Table 70: Torrent Pharmaceuticals Ltd., Financial Overview